Furthermore, as there is evidence that antidiabetic drugs like SGLT2 inhibitors have beneficial effects on patients with diabetes and heart failure further studies are required to investigate if they also have positive effects in heart failure patients without diabetes mellitus. Here, SLC5A2 is linked to heart failure.